Minretumomab (CC-49) is a murine monoclonal antibody derived from B72.3 that specifically binds the TAG-72 tumor-associated antigen. It serves as a research tool for investigating carcinomas, including breast, colon, lung, and pancreatic cancers, in both in vitro and in vivo experimental models.
Concentration:
14.431 mg/mL
Molecular Weight:
~150 kDa
Purity:
99.14% (May vary between batches)
CAS Number:
[195189-17-4]
Target:
Mucin
* VAT and and shipping costs not included. Errors and price changes excepted
